%0 Journal Article
%T Using Extended-Release Injectable Aripiprazole for the Successful Treatment of Depressive Symptoms in Bipolar I Disorder
%A Kuo
%A Joseph
%A Lin
%A Shih-Ku
%J -
%D 2020
%R https://doi.org/10.1155/2020/2615748
%X Extended-release injectable (ERI) aripiprazole is indicated for schizophrenia and maintenance monotherapy of bipolar I disorder. Clinical trials of aripiprazole failed to exhibit efficacy in the treatment of bipolar depression. It has been suggested that relatively high doses, rapid titration of dose, a high dropout rate, and a high placebo effect might be the reasons of its ineffectiveness. Here, we report a case of a 39-year-old woman with bipolar depression who was successfully treated with ERI aripiprazole
%U https://www.hindawi.com/journals/crips/2020/2615748/